NATR Q2 Deep Dive: Lower Guidance, Digital Gains, and Strategic Leadership Hires

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

NATR Cover Image

Wellness products company Nature’s Sunshine (NASDAQ: NATR) fell short of the market’s revenue expectations in Q2 CY2026 as sales only rose 1.9% year on year to $117 million. The company’s full-year revenue guidance of $495 million at the midpoint came in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.21 per share was 22.2% below analysts’ consensus estimates.

Is now the time to buy NATR? Find out in our full research report (it’s free for active Edge members).

Nature's Sunshine (NATR) Q2 CY2026 Highlights:

  • Revenue: $117 million vs analyst estimates of $123.7 million (1.9% year-on-year growth, 5.4% miss)
  • Adjusted EPS: $0.21 vs analyst expectations of $0.27 (22.2% miss)
  • Adjusted EBITDA: $11.33 million vs analyst estimates of $12.19 million (9.7% margin, 7.1% miss)
  • The company dropped its revenue guidance for the full year to $495 million at the midpoint from $507.5 million, a 2.5% decrease
  • EBITDA guidance for the full year is $50 million at the midpoint, below analyst estimates of $52.65 million
  • Operating Margin: 4.7%, in line with the same quarter last year
  • Market Capitalization: $357.7 million

StockStory’s Take

Nature’s Sunshine’s second quarter was met with a significant negative market reaction following results that missed Wall Street’s revenue and non-GAAP profit expectations. Management attributed the quarter’s growth to strong digital channel expansion, particularly in North America and Asia Pacific, and highlighted a 26% increase in digital sales. CEO Ken Romanzi pointed to ongoing investments in digital tools, consultant engagement, and new customer acquisition as key drivers, while acknowledging regional weakness, especially the unexpected slowdown in China.

Looking ahead, management’s guidance for the remainder of 2026 is shaped by ongoing investments in its 'Vision for Growth' strategy, which targets both digital and direct selling expansion. CEO Ken Romanzi emphasized that new leadership hires, including Ruth Perkins as CFO and Janine Weber as President of North America, are expected to accelerate operational improvements and strategic execution. The company remains focused on expanding its digital footprint, launching new products, and pursuing accretive M&A, but cautioned that foreign exchange headwinds and operational issues in China could impact near-term progress.

Key Insights from Management’s Remarks

Management linked the quarter’s underperformance to operational issues in China and foreign exchange pressures, but highlighted digital and geographic expansion as key growth areas.

  • Digital sales momentum: Digital channels in North America performed strongly, with digital sales up 26% and new customer acquisition rising at a similar pace. Social commerce, a form of sales driven by social media platforms, grew 177%, and subscription-based autoship orders made up a larger share of total digital sales, indicating a growing base of recurring revenue.
  • China slowdown and APAC mix: While Asia Pacific overall posted 5% constant currency sales growth, China saw a sharp 20% decline due to operational disruptions, offsetting strong 50% growth in Japan. Management described the issues in China as temporary but acknowledged their negative impact on the region’s overall performance.
  • Product and consultant expansion: The company’s Synergy brand in Asia, particularly in Japan, Taiwan, and Korea, continued to drive growth through a consistent product strategy and a new skincare line. Consultant engagement in new markets like Germany was a focus, with the company adding about 150 consultants per month there.
  • Gross margin improvement: Gross margin reached 73.7%, the highest in over four years, supported by logistics contract renegotiations, manufacturing efficiencies, and disciplined pricing. Management expects margins to remain in the low to mid-73% range for the near future.
  • Leadership transitions: The appointment of Ruth Perkins as CFO and Janine Weber as President of North America reflects a strategic effort to strengthen the leadership team. Romanzi credited outgoing interim financial lead Jon Lanoy for maintaining operational stability during the transition period.

Drivers of Future Performance

Nature’s Sunshine expects digital expansion, direct selling reinvigoration, and international growth to shape its outlook amid ongoing margin improvement and operational risks.

  • Digital and direct selling focus: Management believes continued investment in digital channels and the planned reinvigoration of the North American direct selling model will drive customer engagement and revenue growth, as the company seeks to balance its online and traditional sales approaches.
  • Geographic and product pipeline expansion: The company plans deeper market penetration in existing regions, new country launches (such as Germany and a pending Asian market), and a ramp-up in consultant recruitment. Product innovation, including a new consumer campaign and expanded skincare offerings, is expected to diversify revenue streams.
  • Operational and macro risks: Management highlighted foreign exchange volatility and ongoing operational challenges in China as primary risks. The company’s lowered guidance reflects these headwinds, but leaders remain optimistic that execution on cost controls and new initiatives will support margin stability and eventual growth acceleration.

Catalysts in Upcoming Quarters

Looking ahead, the StockStory team will be closely monitoring (1) the pace of digital and social commerce adoption, especially the conversion of new customers into recurring subscription buyers; (2) the impact of operational recovery efforts in China and the early performance of the Germany market; and (3) the effectiveness of leadership transitions in accelerating North American direct selling growth. The launch trajectory of new product lines and the ability to mitigate foreign exchange headwinds remain additional key signposts.

Nature's Sunshine currently trades at $16.62, down from $20.35 just before the earnings. Is there an opportunity in the stock? Find out in our full research report (it’s free).

High Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  274.48
+2.22 (0.82%)
AAPL  313.33
+0.92 (0.29%)
AMD  483.36
-5.92 (-1.21%)
BAC  63.17
+0.17 (0.27%)
GOOG  353.47
-3.15 (-0.88%)
META  592.10
+2.20 (0.37%)
MSFT  499.99
+0.13 (0.03%)
NVDA  223.96
+4.97 (2.27%)
ORCL  147.02
+3.55 (2.47%)
TSLA  328.58
+9.05 (2.83%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.